Genetic Mutations: Identifies the presence of mutations in the SMN1 gene, responsible for producing an essential protein for motor neuron function. Type Classification: Helps in classifying the type of SMA, such as type 1, type 2, or type 3, based on the severity of symptoms and age of onset. Diagnosis: Used as a tool to confirm the diagnosis of SMA in individuals presenting with symptoms such as muscle weakness or growth delay. Genetic Risk Assessment: Helps families understand potential genetic risks, especially in cases with a family history of the condition. Treatment Guidance: By identifying mutations, doctors can provide personalized treatment options, including gene therapies.

Children showing signs of muscle weakness: Such as delays in sitting, walking, or mobility issues. Individuals with a family history of the condition: To assess genetic risks in families affected by SMA. Newborns with generalized weakness: To determine the potential cause of their weakness. Adults experiencing similar symptoms: Such as muscle weakness or coordination issues. Patients previously diagnosed with SMA: To monitor the condition or determine the exact type of SMA.

Muscle Weakness: General or localized muscle weakness affecting mobility. Delayed Motor Development: Such as delays in sitting, crawling, or walking. Coordination Problems: Difficulty with fine motor control or loss of balance. Muscle Cramps or Spasms: Recurrent cramps or tremors. Breathing Difficulties: Problems with breathing or fluctuations in oxygen levels. Weakness in Muscles Responsible for Swallowing: Leading to feeding difficulties.

What is the goal of this analysis? The goal is to detect genetic mutations associated with Spinal Muscular Atrophy (SMA) for diagnosis and to guide treatment options. How is the analysis performed? A blood sample or tissue sample is taken to analyze for changes in the SMN1 gene. Does the analysis require any special preparation? Generally, no special preparation is needed, but it may be recommended to consult with a doctor about any medications or previous health conditions. How long does it take to get the results? Results are typically available within one to two weeks, depending on the laboratory. Is the analysis painful? Taking a blood sample may cause mild discomfort, but it is generally not a cause for concern. How are the results interpreted? The results are interpreted by a healthcare professional, who will consider medical history and other factors. Is the analysis used to diagnose specific conditions? Yes, it is used to confirm the diagnosis of Spinal Muscular Atrophy and its different types. How can the results improve my health? The results help guide treatment plans and provide appropriate support for patients and their families.

Presence of the SMN1 gene: Indicates that no mutations associated with Spinal Muscular Atrophy are present, meaning there is no underlying condition. Absence of the SMN1 gene or presence of mutations: Suggests the potential presence of the condition or a form of Spinal Muscular Atrophy.

Spinal Muscular Atrophy Test | Lahalak Platform

An advanced genetic test for early detection of SMA mutations, ensuring your child receives an accurate diagnosis and timely treatment for a healthier future.

Prices starts from: 1011.78 SAR

Scientific name: Spinal Muscular Atrophy (SMA) Test

Spinal Muscular Atrophy (SMA) analysis is a genetic test used to identify mutations associated with the condition, which is a hereditary disease that affects motor neurons in the spinal cord, leading to muscle weakness and loss of movement. This analysis is typically performed by taking a blood sample or tissue sample, which is then analyzed to det...

Spinal Muscular Atrophy (SMA) Test - Hope Test for SMA

Service type Genetic Test (Blood)

Duration 10-15 minutes

Fasting Fasting is not required

Prices Starting from 1011.78 SAR

Included Services

Spinal Muscular Atrophy Test
The optimal health guidance based on the result.
Personal support services from Lahalak

Medical Service Information

Purpose Test

Genetic Mutations: Identifies the presence of mutations in the SMN1 gene, responsible for producing an essential protein for motor neuron function.
Type Classification: Helps in classifying the type of SMA, such as type 1, type 2, or type 3, based on the severity of symptoms and age of onset.
Diagnosis: Used as a tool to confirm the diagnosis of SMA in individuals presenting with symptoms such as muscle weakness or growth delay.
Genetic Risk Assessment: Helps families understand potential genetic risks, especially in cases with a family history of the condition.
Treatment Guidance: By identifying mutations, doctors can provide personalized treatment options, including gene therapies.

Recommended groups

Children showing signs of muscle weakness: Such as delays in sitting, walking, or mobility issues.
Individuals with a family history of the condition: To assess genetic risks in families affected by SMA.
Newborns with generalized weakness: To determine the potential cause of their weakness.
Adults experiencing similar symptoms: Such as muscle weakness or coordination issues.
Patients previously diagnosed with SMA: To monitor the condition or determine the exact type of SMA.

Symptoms indicative

Muscle Weakness: General or localized muscle weakness affecting mobility.
Delayed Motor Development: Such as delays in sitting, crawling, or walking.
Coordination Problems: Difficulty with fine motor control or loss of balance.
Muscle Cramps or Spasms: Recurrent cramps or tremors.
Breathing Difficulties: Problems with breathing or fluctuations in oxygen levels.
Weakness in Muscles Responsible for Swallowing: Leading to feeding difficulties.

FAQs

What is the goal of this analysis? The goal is to detect genetic mutations associated with Spinal Muscular Atrophy (SMA) for diagnosis and to guide treatment options.
How is the analysis performed? A blood sample or tissue sample is taken to analyze for changes in the SMN1 gene.
Does the analysis require any special preparation? Generally, no special preparation is needed, but it may be recommended to consult with a doctor about any medications or previous health conditions.
How long does it take to get the results? Results are typically available within one to two weeks, depending on the laboratory.
Is the analysis painful? Taking a blood sample may cause mild discomfort, but it is generally not a cause for concern.
How are the results interpreted? The results are interpreted by a healthcare professional, who will consider medical history and other factors.

Normal Levels

Presence of the SMN1 gene: Indicates that no mutations associated with Spinal Muscular Atrophy are present, meaning there is no underlying condition.
Absence of the SMN1 gene or presence of mutations: Suggests the potential presence of the condition or a form of Spinal Muscular Atrophy.